Piper Sandler raises Nevro stock to Neutral, cuts target to $5.85
Piper Sandler analyst Adam Maeder upgraded shares of Nevro Corp (NYSE:NVRO), a medical device company with a market ...
Piper Sandler announces share repurchase authorization for up to $150M
Piper Sandler (PIPR) announced that its board of directors has authorized the repurchase of up to $150 million of the company’s outstanding ...
Piper Sandler Remains a Sell on Huntington Bancshares (HBAN)
In a report released today, Scott Siefers from Piper Sandler maintained a Sell rating on Huntington Bancshares (HBAN – Research Report), with a ...